ipl-logo

Leukemia Research Paper

1930 Words8 Pages

COMPARATIVE STUDY OF EFFICACY AND TOXICITY OF IMATINIB AND NILOTINIB BASED REGIMENS IN CML PATIENTS
ABSTRACT:
CML, a type of myeloproliferative disorder in which proliferation of bone marrow stem cells is found. Chronic phase, accelerated phase & blast crises are 3 phases of CML.Overall 90% of patients with CML Philadelphia chromosomes are present as a result of a t (9; 22) reciprocal translocation. This chromosomal abnormality is detected by cytogenetics, FISH (fluorescent in situ hybridization). BCR -ABL contains a protein that plays an important role in development of leukemia & it is BCR-ABL oncogene. Imatinib & Nilotinib are used for its treatment. Imatinib mesylate (Glivec, Novartis), a potent competitive inhibitor of the tyrosine kinase …show more content…

Leukemia is best described by increased, unregulated growth of myeloid cells in the bone marrow and assembly of these cells in the blood. A bone marrow disease majorly due to multiplication of mature granulocytes i.e neutrophils,eosinophils & basophils & their precursors. Chronic myeloid leukemia (CML) is a type of myeloproliferative disorder, associated with characteristic translocation called the Philadelphia (ph) chromosome [1]. In this chromosomal translocation, parts of two chromosomes (the 9th and 22nd) shift their places. [1] Consequently, part of the BCR i.e. breakpoint cluster gene from chromosome 22 is fused with the ABL gene on chromosome 9. (Abelson murine leukemia viral oncogene homolog 1 also known as ABL1 is a protein that, in humans, is encoded by the ABL gene). It results in the bone marrow making an enzyme, called tyrosine kinase, that results in too many stem cells to become white blood cells (granulocytes or blasts) CML has three phases. Respectively, each phase of CML is elucidated on the basis of number of blast cells in the blood &bone marrow.Chronic phase,accelerated phase,blast crises are the main stages of CML [2]. Authentic treatment for CML is a bone marrow transplant or an stem cell transplant.Rather there are also four major ways of treatment in CML such as treatment with tyrosine kinase inhibitors(TKI), myelosuppressive or …show more content…

The analysis of data demonstrated that patients belonging to different age groups taking imatinib and nilotinib have a continuous increase in their hemoglobin level. This shows our data is not in harmony with previous findings that, anemia is a main dose dependent side effect of imatinib and nilotinib. Increase in Hb values might be due to some concomitant use of iron therapy; ESAs, PCV etc. white blood cells count is also an important parameter to determine effectiveness of both drugs, results indicate that there is decrease in number of white blood cells during course of therapy. Platelets number in different age groups, taking imatinib, showed some irregularity while data obtained for patients taking nilotinib showed high variations. Neutrophils count is increasing and decreasing with irregularity in patients taking imatinib while neutrophils count in nilotinib therapy, in all age groups, is first decreasing and then again increasing. In general, lymphocyte count is increasing in both treatment groups but in some age groups irregularity has also been observed. There is a continuous rise and fall in monocyte number with both drugs. Eosinophils values are almost constant with imatinib but show decline with nilotinib. (graph 2,3) These findings are indicative of myelo-suppressive effect of imatinib and

Show More
Related
202 Words | 1 Pages

C4564 Description: IC50: 3-AP is a ribonucleotide reductase inhibitor and iron chelator with antitumor activity. Ribonucleotide reductase, the rate-limiting enzyme for de novo DNA synthesis, is an excellent target for chemotherapy. Its increased activity in cancer cells is associated with malignant transformation and proliferation.

Read More
215 Words | 1 Pages

In vitro: Treatment of MM cells with SRT1720 inhibited growth and induced apoptosis in MM cells resistant to bortezomib therapy without significantly affecting the viability of normal cells. Mechanistic studies demonstrated that anti-MM activity of SRT1720 is associated with activation of caspase-3, caspase-8, caspase-9, poly(ADP) ribose

Read More
1134 Words | 5 Pages

Her health being swiftly dropped despite assertive effort of treatment until her family decided to put her in palliative care. Acute Lymphoblastic Leukemia or ALL is one most common blood cancer in children less than 15-year-old of age. Jenny’s diagnosis is acute lymphoblastic leukemia. Ordinarily, blood cells are emerging from an immature cell or stem cell which can give rise to several different cell types. First phase of hematopoiesis or formation of blood

Read More
451 Words | 2 Pages

Per Pauline and Terence, you overlooked quite a few things such as (1) 2 chemo patients with the incorrect treatment dates, (2) hamp1/hamp2

Read More
919 Words | 4 Pages

For example, if you have heparin-induced thrombocytopenia, your doctor will direct you to stop using heparin and prescribe a different blood-thinning drug. Your thrombocytopenia may persist for a week or more despite stopping all heparin therapy. If your platelet level become too low, your doctor can replace blood loss with transfusions of packed red blood cells or platelets. If other treatment does not help your doctor my recommend a splenectomy. An enlarged spleen may harbor too many platelets, causing a decrease in the number of platelets in circulation.

Read More
976 Words | 4 Pages

In the late 1940s, scientific research began taking off as innovative technologies and diseases were being created and discovered. One important field of study during the time was cancer. Like many types of new research, there were a few problems getting the ball on the roll. One problem scientists faced was obtaining cancerous cells that would stay long enough to study. One scientist struggled with this until a particularly unique strand of cells came along.

Read More
1426 Words | 6 Pages

This paper will discuss a more in depth look into the symptoms, diagnosis process, treatment options, medications, prognosis, and ongoing research. What

Read More
766 Words | 4 Pages

T cells are produced to attack the antigens of tumors and B cells are produced to make antibodies that are specific to the antigens of a tumor. An older individual’s immune system could react at a slower

Read More
1062 Words | 5 Pages

Cri-Du-Chat implies "Cry of the cat" in French. It gets its name from its most trademark highlight in infants were they contain a to a great degree specific deafening, weak, mewing cat like cry in the midst of right on time stages brought on by a sporadic change of the larynx that is regularly characteristic for the issue. This issue has various names to it as the Chromosome 5p-issue, Deletion 5p-issue, 5p short issue, Cat cry issue, and Monosomy 5p however most usually known as the Cri-Du-Chat Syndrome. Frequencies of this issue vary between 1 in each 20,000 - 50,000 live births general and as showed by the 5p less Society, around 50 to 60 adolescents are considered with cri du talk in the United States each year. Dr. Jerome Lejeune in 1963 depicted the issue as a hereditary inalienable issue associated with a midway cancelation of the short arm, or p area in chromosome 5 yet in %90 of patients the deletion is sporadic which infers it could happen subjectively and for it being basically natural is just not the circumstance.

Read More
670 Words | 3 Pages

Castleman’s Disease Immune System Castleman’s disease, also known as giant lymph node hyperplasia and CD, is a rare disorder that involves an overgrowth of cells in your body’s lymphatic system. It was first described by Dr. Benjamin Castleman in 1950. CD is not a form of cancer but is called lymphoproliferative disorder, which means there is an abnormal growth of lymphatic cells and is similar to cancers of the immune system. Although it may not be a type of cancer one of the two forms, called multicentric Castleman’s disease, acts just like lymphoma. Many people with multicentric Castleman’s disease actually develop lymphomas.

Read More
1255 Words | 6 Pages

This is a lack of red blood cells caused by low iron in the person’s body. If a person’s body is low on iron, this will make it difficult for the red blood cells to carry oxygen to the tissues. Many people go undiagnosed with this type of anemia. If the deficiency isn’t much, the signs and symptoms may not be very noticeable. With a larger decrease in iron, the signs and symptoms will become more apparent and obvious.

Read More
631 Words | 3 Pages

Lymphoma is a cancer of the blood that occurs when white blood cells acts abnormally (Lymphoma Research Foundation, 2012). Normally white blood cell protects the body from disease and infection(Lymphoma Research Foundation, 2012). Lymphoma can occur in the lymph nodes, bone marrow, spleen, or other organs (Lymphoma Research Foundation, 2012). There is a high chance of survival after treatment for this specific cancer (Balentine, Jerry, 2015). 20,170 people will die from lymphoma in the U.S each year (Medical News Today, 2015).

Read More
730 Words | 3 Pages

Discourse Community : why or why not? In his book, Genre Analysis: English in Academics and Research Settings, linguist John Swales defined discourse community as “groups that have shared goals or purposes, and use communication such as mechanism of intercommunication, participatory mechanism, genre and lexis to achieve their goals."(220). He asserts that the six unique attributes of a discourse community. I applied his specifications to one of my communities that I belonged to prove why my community is a discourse community, and not a speech community.

Read More
933 Words | 4 Pages

The subtype also plays an important role in prognosis. Generally, mature B-cell ALL is the poorest prognosis while T-cell ALL has a better prognosis and all the other types are somewhere in the middle. Chromosome abnormalities are also important as t(4;11), trisomy 8, or deletion 7 are poor prognostic indicators. The Philadelphia chromosome used to be thought of as a poor prognostic indicator but now there are targeted drugs (e.g., tyrosine kinase inhibitors) that can improve the overall prognosis. The response to initial chemotherapy also impacts prognosis as those who go into CR (e.g., less than 5% blasts in the marrow and normal blood counts) within 4-5 weeks have better prognosis while those that do not go into CR have a

Read More
578 Words | 3 Pages

The first phase is the chronic phase. Patients in this phase have less than 10% of immature white blood cells. The symptoms are mild with frequent infections, tiredness, and indigestion. The main treatment is a tyrosine kinase inhibitor (TKI) such as imatinib, nitotinib, or dasatinib.

Read More

More about Leukemia Research Paper

Related Topics

Open Document